NCT01873443View on ClinicalTrials.gov

Long-Term Efficacy and Safety of CT-P10 in Patients With RA

PHASE1CompletedINTERVENTIONAL

Enrollment

87

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Rituximab, MTX, folic acid

Rituximab IV 1000mg MTX 10\~25mg/week Folic acid at least 5mg/week

Trial Locations (1)

Unknown

Inha University College of Medicine Hospital, Incheon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY